These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20979573)

  • 21. Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization study.
    Findling RL; Ginsberg LD; Jain R; Gao J
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):649-62. PubMed ID: 20035583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adults.
    Faraone SV
    J Atten Disord; 2012 Feb; 16(2):128-37. PubMed ID: 20837983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
    Adler LA; Alperin S; Leon T; Faraone S
    Postgrad Med; 2014 Sep; 126(5):17-24. PubMed ID: 25295646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
    Turgay A; Ginsberg L; Sarkis E; Jain R; Adeyi B; Gao J; Dirks B; Babcock T; Scheckner B; Richards C; Lasser R; Findling RL
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):503-11. PubMed ID: 21186969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire.
    Biederman J; Fried R; Hammerness P; Surman C; Mehler B; Petty CR; Faraone SV; Miller C; Bourgeois M; Meller B; Godfrey KM; Baer L; Reimer B
    J Adolesc Health; 2012 Dec; 51(6):601-7. PubMed ID: 23174471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
    Wigal SB; Chae S; Patel A; Steinberg-Epstein R
    Semin Pediatr Neurol; 2010 Dec; 17(4):230-6. PubMed ID: 21183129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm.
    Biederman J; Fried R; Hammerness P; Surman C; Mehler B; Petty CR; Faraone SV; Miller C; Bourgeois M; Meller B; Godfrey KM; Reimer B
    J Psychiatr Res; 2012 Apr; 46(4):484-91. PubMed ID: 22277301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
    Childress AC; Arnold V; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; Lopez FA
    J Atten Disord; 2014 Feb; 18(2):123-32. PubMed ID: 22740112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
    Brown TE; Brams M; Gasior M; Adeyi B; Babcock T; Dirks B; Scheckner B; Wigal T
    Curr Med Res Opin; 2011; 27 Suppl 2():23-33. PubMed ID: 21973229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lisdexamfetamine for treatment of attention-deficit/hyperactivity disorder.
    Cowles BJ
    Ann Pharmacother; 2009 Apr; 43(4):669-76. PubMed ID: 19318601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults.
    Mattingly G
    CNS Spectr; 2010 May; 15(5):315-25. PubMed ID: 20448522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder.
    McIntyre RS; Alsuwaidan M; Soczynska JK; Szpindel I; Bilkey TS; Almagor D; Woldeyohannes HO; Powell AM; Cha DS; Gallaugher LA; Kennedy SH
    Hum Psychopharmacol; 2013 Sep; 28(5):421-7. PubMed ID: 24014142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.
    Steer C; Froelich J; Soutullo CA; Johnson M; Shaw M
    CNS Drugs; 2012 Aug; 26(8):691-705. PubMed ID: 22762726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
    Katic A; Ginsberg L; Jain R; Adeyi B; Dirks B; Babcock T; Scheckner B; Richards C; Lasser R; Turgay A; Findling RL
    J Atten Disord; 2012 Jul; 16(5):384-97. PubMed ID: 21173426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
    Ginsberg L; Katic A; Adeyi B; Dirks B; Babcock T; Lasser R; Scheckner B; Adler LA
    Curr Med Res Opin; 2011 Jun; 27(6):1097-107. PubMed ID: 21438796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial.
    Waxmonsky JG; Waschbusch DA; Babinski DE; Humphrey HH; Alfonso A; Crum KI; Bernstein M; Slavec J; Augustus JN; Pelham WE
    CNS Drugs; 2014 Jul; 28(7):665-77. PubMed ID: 24796970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.
    Roncero C; Álvarez FJ
    Expert Rev Neurother; 2014 Aug; 14(8):849-65. PubMed ID: 24948428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
    Biederman J; Boellner SW; Childress A; Lopez FA; Krishnan S; Zhang Y
    Biol Psychiatry; 2007 Nov; 62(9):970-6. PubMed ID: 17631866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
    Brams M; Moon E; Pucci M; López FA
    Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lisdexamfetamine dimesylate on sleep in children with ADHD.
    Giblin JM; Strobel AL
    J Atten Disord; 2011 Aug; 15(6):491-8. PubMed ID: 20574056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.